Brigitte Lindsay

VP, Finance at Cardiff Oncology

Brigitte Lindsay joined Trovagene in 2012 as Controller and was promoted to Vice President of Finance and Corporate Secretary in early 2019.

She brings extensive biotech experience to the company having previously served as Controller for AviaraDx both before and after acquisition by bioMérieux. Prior to AviaraDx, she was Manager of Financial Reporting and Analysis at publicly traded Carl Zeiss Meditec which is majority owned by the global bioscience optics leader Carl Zeiss AG. Ms. Lindsay has held progressively increasing finance and accounting positions at other leading companies including Philips-Respironics. She adds a global finance perspective having worked for multinational corporations and in both the US and Germany.

Ms. Lindsay received her Diplom Betriebswirt from the Verwaltungs und Wirtsschafts Akademie in Munich, Germany.

Links

Previous companies

Biotheranostics logo
Carl Zeiss Meditec logo
Philips logo

Timeline

  • VP, Finance

    Current role

View in org chart